Product Description
Overall, the global cardiovascular patch repair market was valued at $224 million in 2021. This is expected to increase over the forecast period at a CAGR of 5.6% to reach $327 million by 2028.
The full report suite on the global market for cardiovascular patches includes the cardiac and vascular patch markets.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
The total number of procedures that use cardiovascular patches is expected to grow over the forecast period. This will be driven by an increasing incidence of heart defects in the world as a result of the growing elderly and obese population.
GLOBAL CARDIOVASCULAR PATCH REPAIR MARKET TRENDS
Any procedure involving the use of a cardiovascular patch is typically quite complex and requires the skills of a highly specialized surgeon. Since all of these procedures are open surgeries, they must be done at a hospital, not an ambulatory surgery center (ASC). As a result, there is no downward pressure on pricing, since hospitals are better able to afford the high costs of these patches than ASCs.
GLOBAL CARDIOVASCULAR PATCH REPAIR MARKET SHARE INSIGHTS
Overall, within the global cardiovascular patch repair market there are three dominant competitors: Artivion, LeMaitre Vascular, and Baxter.
In 2021, Artivion, formerly CryoLife, was the leading competitor in the global cardiovascular patch repair market. The company offers the CrypPatch® SynerGraft® (SG) and the CryoPatch® Pericardial Sheet.
GLOBAL CARDIOVASCULAR PATCH REPAIR MARKET SEGMENTATION SUMMARY
- Cardiac Patch Market
- Vascular Patch Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
-
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
